MX356579B - Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol. - Google Patents

Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol.

Info

Publication number
MX356579B
MX356579B MX2013014142A MX2013014142A MX356579B MX 356579 B MX356579 B MX 356579B MX 2013014142 A MX2013014142 A MX 2013014142A MX 2013014142 A MX2013014142 A MX 2013014142A MX 356579 B MX356579 B MX 356579B
Authority
MX
Mexico
Prior art keywords
gastric resistant
weight
ethanol
pharmaceutical
influence
Prior art date
Application number
MX2013014142A
Other languages
English (en)
Other versions
MX2013014142A (es
Inventor
Meier Christian
Hendrik Schattka Jan
Jung Herbert
Krachtus Hedi
Del Rosario Ferrand Jessica
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of MX2013014142A publication Critical patent/MX2013014142A/es
Publication of MX356579B publication Critical patent/MX356579B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con una composición farmacéutica o nutracéutica de resistencia gástrica, que comprende un centro, que contiene un ingrediente activo farmacéutico o nutracéutico y una capa de recubrimiento de resistencia gástrica en el centro, en donde la capa de recubrimiento de resistencia gástrica comprende por lo menos 30% en peso de un copolímero de (met)acrilato, que comprende unidades polimerizadas de 10 a 40% en peso de ácido acrílico o metacrílico, 10 a 80% en peso de un éster de alquilo C4 a C18 de ácido acrílico o metacrílico y, opcionalmente, 0 a 60% en peso de otro monómero vinílico, por lo que la liberación del ingrediente activo farmacéutico o nutracéutico no es mayor de 10% bajo condiciones in vitro, a pH 1.2 después de 2 horas en un medio de acuerdo con USP, con y sin la adición de etanol al 20% (v/v).
MX2013014142A 2011-06-17 2012-06-12 Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol. MX356579B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2011060098 2011-06-17
PCT/EP2012/061051 WO2012171884A1 (en) 2011-06-17 2012-06-12 Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol

Publications (2)

Publication Number Publication Date
MX2013014142A MX2013014142A (es) 2014-01-23
MX356579B true MX356579B (es) 2018-06-05

Family

ID=46354217

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014142A MX356579B (es) 2011-06-17 2012-06-12 Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol.

Country Status (13)

Country Link
US (1) US9775815B2 (es)
JP (1) JP6099638B2 (es)
KR (1) KR101902602B1 (es)
CN (1) CN103501768B (es)
AU (1) AU2012269187A1 (es)
BR (1) BR112013027484A8 (es)
CA (1) CA2839525C (es)
ES (1) ES2600853T3 (es)
HU (1) HUE030548T2 (es)
IL (1) IL228396A0 (es)
MX (1) MX356579B (es)
RU (1) RU2649806C2 (es)
WO (1) WO2012171884A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013027484A8 (pt) 2011-06-17 2022-07-05 Evonik Roehm Gmbh Composição farmacêutica ou nutracêutica com resistência gástrica, e uso de um polímero de (met)acrilato
ES2786312T3 (es) * 2014-11-26 2020-10-09 Evonik Operations Gmbh Composición farmacéutica o nutracéutica con resistencia contra la influencia de etanol
WO2019052845A1 (en) 2017-09-14 2019-03-21 Evonik Röhm Gmbh POLYMER AND PHARMACEUTICAL FORM WITH PROLONGED RELEASE PROPERTIES AND RESISTANCE TO THE INFLUENCE OF ETHANOL
JP2021515778A (ja) * 2018-03-09 2021-06-24 エボニック オペレーションズ ゲーエムベーハー エタノールの影響に対する耐性を有するポリマー混合物
SG11202005947RA (en) 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
WO2019226519A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
CN109232795A (zh) * 2018-09-21 2019-01-18 佛山市森昂生物科技有限公司 一种防水型高韧性包衣材料的制备方法
BR112021017735A2 (pt) * 2019-03-11 2021-11-16 Evonik Operations Gmbh Forma de dosagem que compreende uma matriz polimérica
JP7299595B2 (ja) * 2019-06-07 2023-06-28 日本曹達株式会社 微粒子用の湿式コーティング剤

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9414065U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE9414066U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
DE10220470A1 (de) * 2002-04-30 2003-11-20 Roehm Gmbh ph-sensitives Polymer
DE10011447A1 (de) 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
WO2002032431A1 (fr) * 2000-10-16 2002-04-25 Hisamitsu Pharmaceutical Co., Inc. Compositions pour preparations externes
DE20220902U1 (de) * 2001-12-19 2004-06-09 Astrazeneca Ab Neuer Filmüberzug
DE10208335A1 (de) 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
JP3727290B2 (ja) * 2002-07-22 2005-12-14 日本カラコン株式会社 腸溶性水系コーティング剤
DE10250543A1 (de) 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
US8168228B2 (en) * 2003-10-17 2012-05-01 Sandoz Ag Antibiotic clarithromycin micropellet compositions
AU2003292509B2 (en) * 2003-12-15 2007-08-02 Council Of Scientific And Industrial Research Taste masked pharmaceutical compositions comprising bitter drug and pH sensitive polymer
DE102004011349A1 (de) 2004-03-05 2005-09-22 Basf Ag Wässrige Polymerdispersion auf Basis von Alkyl(meth)-acrylaten
US7446157B2 (en) 2004-12-07 2008-11-04 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
DE102005024614A1 (de) * 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
DE102006051020A1 (de) 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
CN100465201C (zh) * 2007-04-25 2009-03-04 上海大学 用作药物肠溶包衣材料的水溶性丙烯酸系树脂乳液的制备方法
US9700520B2 (en) * 2007-09-21 2017-07-11 Evonik Roehm Gmbh PH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
CA2699224C (en) * 2007-09-21 2014-12-16 Evonik Roehm Gmbh Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol
EP2326313B1 (en) 2008-09-24 2015-03-04 Evonik Röhm GmbH Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol
US9757343B2 (en) 2008-09-24 2017-09-12 Evonik Röhm Gmbh PH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
CA2755808C (en) 2009-03-18 2016-01-19 Evonik Roehm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients
BRPI0924427A2 (pt) 2009-03-18 2016-01-26 Evonik Roehm Gmbh composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma
CN103501767A (zh) 2011-06-17 2014-01-08 赢创罗姆有限公司 适合于药物或营养制品剂型的包衣组合物
BR112013027484A8 (pt) 2011-06-17 2022-07-05 Evonik Roehm Gmbh Composição farmacêutica ou nutracêutica com resistência gástrica, e uso de um polímero de (met)acrilato
AU2011370762A1 (en) 2011-06-17 2013-11-14 Evonik Rohm Gmbh Coating composition suitable for pharmaceutical or nutraceutical dosage forms

Also Published As

Publication number Publication date
KR20140045942A (ko) 2014-04-17
ES2600853T3 (es) 2017-02-13
RU2014101230A (ru) 2015-07-27
US20140141092A1 (en) 2014-05-22
MX2013014142A (es) 2014-01-23
US9775815B2 (en) 2017-10-03
BR112013027484A8 (pt) 2022-07-05
RU2649806C2 (ru) 2018-04-04
CA2839525C (en) 2019-07-02
JP2014517020A (ja) 2014-07-17
HUE030548T2 (en) 2017-05-29
WO2012171884A1 (en) 2012-12-20
BR112013027484A2 (pt) 2017-01-10
AU2012269187A1 (en) 2013-09-26
CN103501768B (zh) 2016-11-09
IL228396A0 (en) 2016-10-31
CN103501768A (zh) 2014-01-08
CA2839525A1 (en) 2012-12-20
JP6099638B2 (ja) 2017-03-22
KR101902602B1 (ko) 2018-09-28

Similar Documents

Publication Publication Date Title
MX356579B (es) Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol.
WO2007006353A3 (de) Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten
EP2492330A3 (en) Removable Water-Dispersible Acrylic Pressure-Sensitive Adhesive Composition and Pressure-Sensitive Adhesive Sheet
MX2017006858A (es) Composición farmacéutica o nutracéutica con resistencia a la influencia del etanol.
IL167334A (en) Multilayer dosage forms which contain active substances and which comprise a neutral core and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers
BRPI0513743A (pt) medicamento em uma forma de multicamada
MX360389B (es) Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico.
ATE553754T1 (de) Pharmazeutische zusammensetzung mit kontrollierter wirkstoffabgabe für wirkstoffe mit guter löslichkeit in wasser
MX2011009669A (es) Composición farmacéutica de liberación controlada con resistencia a la influencia de etanol mediante un revestimiento compuesto de una mezcla polimérica y excipientes.
TW200635963A (en) Partially neutralized anionic (meth)acrylate copolymer
MX2017015465A (es) Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol.
ES2531252T3 (es) Copolímeros aleatorios de metacrilatos y acrilatos
WO2008049657A3 (de) Verwendung von (meth)acrylat-copolymeren in retard-arzneiformen zur verringerung des einflusses von ethanol auf die wirkstofffreisetzung
MX2012001177A (es) Composicion en polvo o granulada que consta de un copolimero, una sal de un acido graso monocarboxilico y un acido graso monocarboxilico y/o un alcohol graso.
WO2013095993A3 (en) Water resistant personal care polymers
RU2014101227A (ru) Композиция покрытия, подходящая для фармацевтических или нутрицевтических лекарственных форм
WO2013072118A3 (de) Mittel zur temporären verformung keratinischer fasern auf grundlage einer kombination spezifischer filmbildender polymere
MX2015010449A (es) Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos.
WO2012092486A3 (en) Modified release benzimidazole formulations
MX2010007578A (es) Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa.
MX2010007579A (es) Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada.
CA2797809A1 (en) Enteric tablet
WO2008115961A3 (en) Sustained-release composition
MX2020002790A (es) Polimero y forma de dosis con propiedades de liberacion sostenida y resistencia contra la influencia de etanol.
CY1111318T1 (el) Διαδερματικη φαρμακοτεχνικη μορφη στεροειδους

Legal Events

Date Code Title Description
FG Grant or registration